Vulnerability in Hospira Lifecare Pca3

CVE-2014-5406

The Hospira LifeCare PCA Infusion System before 7.0 does not validate network traffic associated with sending a (1) drug library, (2) software update, or (3) configuration change, which allows remote attackers to modify settings or medication data via packets on the (a) TELNET, (b) HTTP, (c) HTTPS, or (d) UPNP port. NOTE: this issue might overlap CVE-2015-3459.

Published · last modified .

CVSS v2 metric

CVSS v2 base score 7.6 (High). Vector: AV:N/AC:H/Au:N/C:C/I:C/A:C. This CVE predates CVSS v3 and has no v3 score from NVD.

EPSS exploit prediction

EPSS: 0.012 (68.0th percentile), scored .

Low probability of exploitation in the next 30 days, but still tracked. 68th percentile — 68.0% of CVEs in the catalogue have a lower EPSS than this one. How to read EPSS.

EPSS trend (30 days)EPSS over the last 30 days for CVE-2014-5406: held from 0.012 to 0.012.

EPSS over last 30 days · oldest: 0.012 · newest: 0.012 · change: 0.000

Affected products

Weakness classification (CWE)

References